DGAP-News: LR Global Holding GmbH publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm
2022. január 24., hétfő, 15:09
LR Global Holding GmbH publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm Ahlen, 24 January 2022 - On 3 February 2021, LR Global Holding GmbH ("LR Global Holding") issued senior secured floating rate bonds (2021/2025) in an amount of EUR 125,000,000 (the "Bonds"). Under the terms and conditions for the Bonds, LR Global Holding has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For the purpose of the admission to trading, LR Global Holding has prepared a listing prospectus which has been approved by the Swedish Financial Supervisory Authority today. LR Global Holding will submit an application for admission to trading of the Bonds and the first trading day on Nasdaq Stockholm is expected to be on or about 26 January 2022. The prospectus will be available at LR Global Holding"s website, ir.lrworld.com/en/bond and the Swedish Financial Supervisory Authority"s website www.fi.se. The processing of Aloe Vera has been one of the core competencies of LR Health & Beauty for almost 20 years. In Ahlen, the company has established one of the most modern Aloe Vera production sites for Aloe Vera Drinking Gels in Europe. LR has been firmly established in the market for over 35 years with around 1,200 employees and more than 300,000 registered community members. Investor Relations contact:
|
Language: | English |
Company: | LR Global Holding GmbH |
Kruppstr. 55 | |
59227 Ahlen | |
Germany | |
Phone: | +49 238270600 |
E-mail: | info@lrworld.com |
Internet: | www.lrworld.com |
ISIN: | NO0010894850 |
WKN: | A3H3FM |
Listed: | Regulated Unofficial Market in Frankfurt |
EQS News ID: | 1272084 |
End of News | DGAP News Service |
1272084 24.01.2022
Közzétételek - archívum
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]